← Back to Search

Exoskeleton

Trexo Plus Pediatric Exoskeleton for Cerebral Palsy

Q: Who is eligible to participate in this experiment?

<p>This trial is looking for 10 children with <a href="https://www.withpower.com/clinical-trials/cerebral-palsy">cerebral palsy</a>, between the ages of 4 and 7. To qualify for the study, these participants must also weigh between 23-46 kgs, have a leg length (hip to floor) of 40-56 cm., be classified as GMFCS Level IV equivalent or higher, and possess adequate knee/ hip ranges of motion which will permit them to wear an exoskeleton comfortably.</p>

N/A

Waitlist Available

Led By Virginia Wright

Research Sponsored by Holland Bloorview Kids Rehabilitation Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, following 6 weeks of intervention, 1 month post-intervention

Awards & highlights

Study Summary

This trial will study if robotic exoskeletons can help non-ambulatory children with CP & similar conditions walk & experience more meaningful participation in life & community.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, following 6 weeks of intervention, 1 month post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, following 6 weeks of intervention, 1 month post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, following 6 weeks of intervention, 1 month post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Canadian Occupational Performance Measure (COPM) - changes from Baseline

Diffusion Magnetic resonance imaging (MRI) - changes from Baseline

Goal Attainment Scaling (GAS) - changes from Baseline

+4 more

Secondary outcome measures

Directional Mobility Assessment (DMA) - changes from Baseline

PEDI-CAT Questionnaire - changes from Baseline

Passive range of motion (ROM) - changes from Baseline

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Trexo Plus Pediatric ExoskeletonExperimental Treatment1 Intervention

Experimental lower-limb wearable pediatric exoskeleton used biweekly in clinical and school settings.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Holland Bloorview Kids Rehabilitation HospitalLead Sponsor

67 Previous Clinical Trials

14,064 Total Patients Enrolled

24 Trials studying Cerebral Palsy

4,034 Patients Enrolled for Cerebral Palsy

University of TorontoOTHER

690 Previous Clinical Trials

1,019,633 Total Patients Enrolled

3 Trials studying Cerebral Palsy

82 Patients Enrolled for Cerebral Palsy

Virginia WrightPrincipal InvestigatorHolland Bloorview Kids Rehabilitation Hospital

1 Previous Clinical Trials

20 Total Patients Enrolled

1 Trials studying Cerebral Palsy

20 Patients Enrolled for Cerebral Palsy

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are persons over the age of fifty being enrolled in this examination?

"The age range for this trial is 4 to 7 years of age, in accordance with the predetermined eligibility criteria."

Answered by AI

Are there current opportunities to participate in this research study?

"Unfortunately, the clinical trial is not currently enrolling new participants. As indicated on clinicialtrials.gov, this study was originally posted on March 1st 2023 and updated lastly on February 6th 2023. Fortunately, there are 155 other trials actively seeking patients at present time."

Answered by AI

Who is eligible to participate in this experiment?

"This trial is looking for 10 children with cerebral palsy, between the ages of 4 and 7. To qualify for the study, these participants must also weigh between 23-46 kgs, have a leg length (hip to floor) of 40-56 cm., be classified as GMFCS Level IV equivalent or higher, and possess adequate knee/ hip ranges of motion which will permit them to wear an exoskeleton comfortably."

Answered by AI

What key outcomes is the research aiming to achieve?

"This clinical trial's primary outcome, which will be assessed at Baselines and after 6 weeks of intervention as well as a month post-intervention, is to measure changes in Mechanomyography. Secondary objectives monitor fluctuations from Baseline through the Directional Mobility Assessment (DMA), Sitting Assessment for Children with Neuromotor Dysfunction (SACND) - rating scale of 1-4, and finally by tracking alterations via parent-report on PEDI-CAT Questionnaire."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Exoskeleton-assisted Physiotherapy for Children With Mobility Impairments

2023. "Exoskeleton-assisted Physiotherapy for Children With Mobility Impairments". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05463211.